Richard Pazdur Selected Research

Renal Cell Carcinoma (Grawitz Tumor)

3/2024	Cytoreductive nephrectomy in the era of immune checkpoint inhibitors: a U.S. FDA pooled analysis.
2/2024	A Pooled Analysis of Treatment-Free Survival in Advanced Renal Cell Carcinoma.
10/2023	A U.S. Food and Drug Administration-pooled Analysis of Frontline Combination Treatment Survival Benefits by Risk Groups in Metastatic Renal Cell Carcinoma.
11/2022	FDA Approval Summary: Belzutifan for von Hippel-Lindau Disease-Associated Tumors.
1/2022	FDA Approval Summary: Tivozanib for Relapsed or Refractory Renal Cell Carcinoma.
1/2020	Eligibility and Radiologic Assessment for Adjuvant Clinical Trials in Kidney Cancer.
1/2017	U.S. Food and Drug Administration Approval: Cabozantinib for the Treatment of Advanced Renal Cell Carcinoma.
1/2017	FDA Approval Summary: Nivolumab in Advanced Renal Cell Carcinoma After Anti-Angiogenic Therapy and Exploratory Predictive Biomarker Analysis.
1/2010	FDA approval summary: temsirolimus as treatment for advanced renal cell carcinoma.
1/2010	FDA drug approval summary: bevacizumab plus interferon for advanced renal cell carcinoma.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard Pazdur Research Topics

Disease

93	Neoplasms (Cancer) 10/2023 - 01/2002
55	Diarrhea 11/2023 - 05/2002
48	Disease Progression 03/2024 - 01/2002
47	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 01/2003
47	Nausea 02/2024 - 05/2002
44	Fatigue 11/2023 - 10/2005
38	Breast Neoplasms (Breast Cancer) 02/2024 - 01/2002
30	Exanthema (Rash) 11/2023 - 10/2002
27	Vomiting 02/2024 - 05/2002
24	Neutropenia 01/2020 - 01/2005
21	Thrombocytopenia (Thrombopenia) 10/2021 - 01/2005
18	Constipation 01/2023 - 03/2005
18	Hypertension (High Blood Pressure) 01/2023 - 12/2006
17	Multiple Myeloma 01/2023 - 01/2002
16	Prostatic Neoplasms (Prostate Cancer) 03/2024 - 01/2002
16	Anemia 12/2023 - 06/2008
16	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 03/2002
15	Abdominal Pain (Pain, Abdominal) 11/2023 - 06/2007
15	Headache (Headaches) 11/2022 - 03/2005
14	Infections 06/2023 - 06/2005
14	Asthenia 12/2022 - 05/2006
14	Hemorrhage 01/2022 - 10/2002
13	Renal Cell Carcinoma (Grawitz Tumor) 03/2024 - 12/2006
11	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2023 - 01/2010
10	Carcinoma (Carcinomatosis) 03/2024 - 01/2004
10	Fever (Fevers) 11/2023 - 03/2005
10	Musculoskeletal Pain 09/2023 - 09/2014
10	Alopecia (Baldness) 01/2023 - 10/2005
10	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2022 - 01/2002
9	Cough 12/2022 - 07/2014
9	Dyspnea (Shortness of Breath) 01/2022 - 06/2007
9	Arthralgia (Joint Pain) 01/2022 - 03/2005
9	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020 - 09/2006
8	Ovarian Neoplasms (Ovarian Cancer) 10/2023 - 10/2006
8	Hepatocellular Carcinoma (Hepatoma) 09/2023 - 01/2009
8	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2023 - 01/2002
8	Myalgia 01/2023 - 05/2002
8	Edema (Dropsy) 01/2022 - 05/2002
8	Peripheral Nervous System Diseases (PNS Diseases) 01/2022 - 05/2006
8	Proteinuria 01/2021 - 06/2007
8	Melanoma (Melanoma, Malignant) 01/2018 - 01/2012
7	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2002
6	Pain (Aches) 01/2022 - 07/2003
6	Mucositis 01/2018 - 01/2007
6	Lung Neoplasms (Lung Cancer) 01/2018 - 10/2014
6	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 08/2015 - 02/2008
5	Stomatitis 01/2021 - 06/2007
5	Philadelphia Chromosome 11/2018 - 06/2003
5	Dysgeusia (Parageusia) 12/2017 - 01/2007
5	Anorexia 01/2013 - 03/2005
5	Blast Crisis (Blast Phase) 01/2008 - 01/2002
4	Pruritus (Itching) 09/2023 - 03/2015
4	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 05/2018

Drug/Important Bio-Agent (IBA)

28	PlatinumIBA 10/2023 - 01/2003
18	ErbB Receptors (EGF Receptor)IBA 02/2024 - 08/2005
17	pembrolizumabIBA 03/2024 - 01/2016
16	Hormones (Hormone)IBA 08/2023 - 01/2002
14	Imatinib Mesylate (Gleevec)FDA Link 01/2023 - 01/2002
13	NivolumabIBA 10/2023 - 01/2016
13	Biomarkers (Surrogate Marker)IBA 01/2023 - 03/2007
13	TabletsIBA 01/2022 - 01/2002
11	Trastuzumab (Herceptin)FDA Link 11/2023 - 10/2008
11	Docetaxel (Taxotere)FDA Link 01/2018 - 01/2003
10	Immune Checkpoint InhibitorsIBA 03/2024 - 02/2017
10	Irinotecan (Camptosar)FDA LinkGeneric 11/2023 - 05/2002
10	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2023 - 01/2004
10	Anaplastic Lymphoma KinaseIBA 07/2021 - 04/2014
9	Cisplatin (Platino)FDA LinkGeneric 03/2024 - 01/2004
9	Bevacizumab (Avastin)FDA Link 01/2021 - 05/2004
8	Sorafenib (BAY 43-9006)FDA Link 01/2024 - 12/2006
8	atezolizumabIBA 01/2023 - 01/2017
8	Alanine Transaminase (SGPT)IBA 01/2021 - 10/2002
8	Fluorouracil (Carac)FDA LinkGeneric 09/2016 - 03/2002
7	Tyrosine Kinase InhibitorsIBA 02/2024 - 12/2007
7	Fulvestrant (Faslodex)FDA Link 08/2023 - 01/2002
7	taxaneIBA 01/2023 - 12/2004
7	Transaminases (Aminotransferases)IBA 01/2020 - 08/2007
7	Bortezomib (Velcade)FDA Link 11/2017 - 01/2003
6	Phosphotransferases (Kinase)IBA 01/2023 - 12/2006
6	IpilimumabIBA 01/2022 - 07/2017
6	CrizotinibIBA 01/2022 - 04/2014
6	Capecitabine (Xeloda)FDA Link 01/2021 - 05/2004
6	Letrozole (Femara)FDA LinkGeneric 01/2020 - 03/2002
6	Aspartate Aminotransferases (Aspartate Transaminase)IBA 08/2017 - 10/2002
5	Lipase (Acid Lipase)FDA Link 01/2021 - 12/2006
5	B7-H1 AntigenIBA 01/2021 - 01/2016
5	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2019 - 06/2003
5	Erlotinib Hydrochloride (CP 358,774)FDA Link 07/2014 - 08/2005
5	Pemetrexed (MTA)FDA Link 01/2010 - 01/2004
4	Poly(ADP-ribose) Polymerase InhibitorsIBA 03/2024 - 01/2015
4	enzalutamideIBA 03/2024 - 11/2013
4	ivosidenibIBA 11/2023 - 01/2019
4	Aromatase InhibitorsIBA 08/2023 - 01/2018
4	LigandsIBA 01/2023 - 01/2016

Therapy/Procedure

125	Therapeutics 03/2024 - 01/2002
64	Drug Therapy (Chemotherapy) 03/2024 - 10/2002
12	Immunotherapy 03/2024 - 01/2016
10	Castration 03/2024 - 11/2013
7	Neoadjuvant Therapy 10/2023 - 07/2014
6	Radiotherapy 01/2022 - 07/2003